Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and activities of transcriptional factors involved in both cancer initiation and progression through alteration of either DNA or the structural components of chromatin. Recently, the role of gene repression through modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jiahuai, Cang, Shundong, Ma, Yuehua, Petrillo, Richard L, Liu, Delong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827364/
https://www.ncbi.nlm.nih.gov/pubmed/20132536
http://dx.doi.org/10.1186/1756-8722-3-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827364/
https://www.ncbi.nlm.nih.gov/pubmed/20132536
http://dx.doi.org/10.1186/1756-8722-3-5

Ejemplares similares